Literature DB >> 34221838

6p.21 translocation renal cell carcinoma in the elderly: radiological findings mimicking fat poor angiomyolipoma or papillary renal cell carcinoma.

Yoichiro Tohi1, Satoshi Harada1, Naoto Kuroda2, Kenichi Tanaka3, Kosuke Inoue4, Kyuichi Kadota4, Reiji Haba4, Yoshihiro Nishiyama3, Nobufumi Ueda1, Mikio Sugimoto1.   

Abstract

6p21 translocation renal cell carcinoma (RCC) harboring TFEB gene fusion is a newly classified microphthalmia-associated transcription (MiT) factor-family translocation RCC with early onset. We present a case of 78-year-old man with a 6p21 translocation RCC that was diagnosed after partial nephrectomy for an incidental renal tumor on computed tomography (CT). Unenhanced CT showed a 20 mm, mildly low-density mass in the right kidney. Contrast-enhanced CT showed a heterogeneous and prolonged, mild enhancement in the tumor. On magnetic resonance imaging, the tumor showed iso-intensity within the renal parenchyma on T1-weighted-imaging (WI), low intensity on T2WI, and no restricted diffusion with low signal on diffusion-weighted imaging, with no clear tumor pseudocapsule. Fat poor angiomyolipoma and non-clear cell RCC were listed as differential diagnoses. Robot-assisted partial nephrectomy was successfully performed. Fluorescence in situ hybridization study of the resected tumor confirmed TFEB gene break, and the patient was diagnosed with a 6p21 translocation RCC. The patient is doing well without recurrence after 2.5 years of follow-up. Our patient is the oldest patient reported in previous literature. © The Japan Society of Clinical Oncology 2021.

Entities:  

Keywords:  6p21 translocation; Renal cell carcinoma; TFEB

Year:  2021        PMID: 34221838      PMCID: PMC8206449          DOI: 10.1007/s13691-021-00486-y

Source DB:  PubMed          Journal:  Int Cancer Conf J        ISSN: 2192-3183


  9 in total

1.  Renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: radiological findings mimicking papillary subtype.

Authors:  Hiroki Kato; Masayuki Kanematsu; Shigeaki Yokoi; Kousei Miwa; Kengo Horie; Takashi Deguchi; Yoshinobu Hirose
Journal:  J Magn Reson Imaging       Date:  2011-01       Impact factor: 4.813

2.  Renal carcinoma with (6;11)(p21;q12) translocation: report of an adult case.

Authors:  Akira Ishihara; Yasuhiro Yamashita; Hiroki Takamori; Naoto Kuroda
Journal:  Pathol Int       Date:  2011-08-07       Impact factor: 2.534

3.  Molecular heterogeneity of TFE3 activation in renal cell carcinomas.

Authors:  Stephan Macher-Goeppinger; Wilfried Roth; Nina Wagener; Markus Hohenfellner; Roland Penzel; Axel Haferkamp; Peter Schirmacher; Sebastian Aulmann
Journal:  Mod Pathol       Date:  2011-10-28       Impact factor: 7.842

4.  t(6;11) renal cell carcinoma (RCC): expanded immunohistochemical profile emphasizing novel RCC markers and report of 10 new genetically confirmed cases.

Authors:  Nathaniel E Smith; Peter B Illei; Mohamed Allaf; Nilda Gonzalez; Kerry Morris; Jessica Hicks; Angelo Demarzo; Victor E Reuter; Mahul B Amin; Jonathan I Epstein; George J Netto; Pedram Argani
Journal:  Am J Surg Pathol       Date:  2014-05       Impact factor: 6.394

5.  Clinicopathological study of 5 cases of renal cell carcinoma with t(6;11)(p21;q12).

Authors:  Naoto Kuroda; Kenji Yorita; Naomi Sasaki; Akira Ishihara; Keiko Matsuura; Tsutomu Daa; Shintaro Mori; Aya Sasaki; Shuji Mikami; Kazuto Shigematsu; Yoji Nagashima
Journal:  Pol J Pathol       Date:  2017       Impact factor: 1.072

6.  Renal carcinomas with the t(6;11)(p21;q12): clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR.

Authors:  Pedram Argani; Marick Laé; Brian Hutchinson; Victor E Reuter; Margaret H Collins; John Perentesis; John E Tomaszewski; John S J Brooks; Geza Acs; Julia A Bridge; Sara O Vargas; Ian J Davis; David E Fisher; Marc Ladanyi
Journal:  Am J Surg Pathol       Date:  2005-02       Impact factor: 6.394

Review 7.  Review of renal carcinoma with t(6;11)(p21;q12) with focus on clinical and pathobiological aspects.

Authors:  Naoto Kuroda; Azusa Tanaka; Naomi Sasaki; Akira Ishihara; Keiko Matsuura; Masatsugu Moriyama; Yoji Nagashima; Keiji Inoue; Fredrik Petersson; Guido Martignoni; Michal Michal; Ondrej Hes
Journal:  Histol Histopathol       Date:  2013-02-21       Impact factor: 2.303

8.  MiT translocation renal cell carcinomas: two subgroups of tumours with translocations involving 6p21 [t (6; 11)] and Xp11.2 [t (X;1 or X or 17)].

Authors:  Milan Hora; Tomáš Urge; Ivan Trávníček; Jiří Ferda; Zdeněk Chudáček; Tomáš Vaněček; Michal Michal; Fredrik Petersson; Naoto Kuroda; Ondřej Hes
Journal:  Springerplus       Date:  2014-05-13

Review 9.  Translocation Renal Cell Carcinoma: An Update on Clinicopathological and Molecular Features.

Authors:  Kentaro Inamura
Journal:  Cancers (Basel)       Date:  2017-08-29       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.